
BBNX
Healthcare · Medical Devices · $892.7M market cap
$16.42-0.09 (-0.5%)Nov 13, 4:18 PM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · +18.6% over 90 days · 30-day revisions 2 up, 0 down
Beat estimates in 4 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Oct 27, 2026 | After the close | -0.53 | -0.52 | +1.9% |
| Jul 29, 2026 | After the close | -0.62 | -0.53 | +14.5% |
| Apr 21, 2026 | After the close | -0.45 | -0.36 | +20.0% |
| Feb 17, 2026 | Time not confirmed | -0.38 | -0.30 | +21.1% |
| Oct 28, 2025 | After the close | -0.41 | -0.33 | +19.5% |
| Jul 29, 2025 | After the close | -0.47 | -0.27 | +42.6% |
| May 6, 2025 | After the close | -0.51 | -0.93 | -82.4% |
| Mar 25, 2025 | Time not confirmed | -1.22 | -2.72 | -123.6% |
| Nov 27, 2024 | Time not confirmed | — | -0.82 | — |
Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes. It offers iLet Bionic Pancreas, an insulin delivery device for the treatment of type 1 diabetes in adults and children six years of age and older. The company is also developing Patch Pump, an…